CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 58 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-15 | Agopyan Nadia VP, Regulatory Affairs | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2019-08-14 | Hoang Peter L. President and CEO | Purchase | +10,000 | $4.62 | $46K | 189,711 |
| 2019-08-06 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2019-05-09 | Eansor Norman David Director | Grant or award | +7,260 | 7,260 | ||
| 2019-05-09 | Wilson John Robert Director | Grant or award | +7,260 | 6,068,043 | ||
| 2019-05-09 | Laskow-Pooley David Director | Grant or award | +7,260 | 25,543 | ||
| 2019-05-09 | Wasserman Frederick Gerald Director | Grant or award | +7,260 | 25,543 | ||
| 2018-11-27 | Kim Anthony H. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2018-10-19 | Hoang Peter L. Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +1,359,855 | 1,359,855 | ||
| 2018-10-19 | Hoang Peter L. Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-10-19 | Vera Juan Director | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2018-10-19 | Loiacono Michael Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-10-17 | Eansor Norman David Director | Grant or award · Non-Employee Director Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2018-10-17 | Wilson John Robert Director | Grant or award · Non-Employee Director Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2018-10-16 | Silverman Joshua Director | Grant or award | +4,106 | 17,221 | ||
| 2018-10-16 | Grisewood Sherry Director | Grant or award | +4,106 | 19,582 | ||
| 2018-10-16 | Reddish Mark Director | Grant or award | +4,106 | 36,110 | ||
| 2018-10-16 | Laskow-Pooley David Director | Grant or award | +5,168 | 18,283 | ||
| 2018-10-16 | Wasserman Frederick Gerald Director | Grant or award | +5,168 | 18,283 |
Page 6 of 6 · 119 trades